Clinical Trial

Sing Out Loud: A Choral Singing Program for Persons Living With Dementia

Study acronym: SOL
Completed
View on ClinicalTrials.gov →
Summary
This study intends to investigate whether a singing programme for nursing home residents living with dementia can reduce the mental and physiological effects of dementia. The main questions it aims to answer are: 1. Does participating in the Sing Out Loud (SOL) singing intervention lead to an improvement in the physiological well-being (increase in oxytocin and reduction in cortisol levels) of persons living with dementia (PWDs) in nursing homes? 2. Will participation in the SOL singing intervention result in an improvement in PWDs' overall mood, temperament, and mental health (indicated by symptoms such as apathy, aggression, and depression). Researchers will compare the singing group to the control group to see if they exhibit reduced levels of apathy, aggression, and depression, and whether their levels of oxytocin and cortisol (collected via salivary biomarkers) have increased and decreased, respectively. Researchers will compare the SOL singing intervention with a waitlist control group to see if the SOL singing intervention increases the feelings of social connection, reduces stress, or improves the symptoms of dementia in nursing home residents. Participants will be randomly assigned to a singing intervention or waitlist control group. The intervention involves an 8-week long singing programme with one practice session a week, culminating in an additional full dress rehearsal and private showcase performance for their family members at a concert venue.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-11.
Status change: Not Yet Recruiting → Completed 2026-06-12
Trial Details
NCT Number NCT06880237
Lead Sponsor National University of Singapore
Collaborators: Esplanade, APEX Harmony Lodge
Conditions Dementia, Nursing Homes Residents
Enrollment 26 participants
Start Date 2025-03-12
Primary Completion 2025-05-26 (estimated)
Study Completion 2025-06-10 (estimated)
Updated on ClinicalTrials.gov 2026-06-16